Institut de Cancérologie de Lorraine

Vandœuvre-lès-Nancy, Grand Est 54519

0 studies enrolling now · 1 studies all time

What they study most

Squamous Cell Carcinoma of Head and Neck

Studies at this site

• A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) — Completed